A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 535-541

  Jacobs, Philippe ^a,b   Radzioch, Danuta ^b   Stevenson, Mary M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HELPER CELL; LIVER; MALARIA; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; SPLEEN; TISSUE SPECIFICITY;

EID: 0030052075     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.535-541.1996     Document Type: Article

References (38)

1. Bate, C. A. W., J. Taverne, and J. H. L. Playfair. 1989. Soluble malaria antigens are toxic and induce the production of tumour necrosis factor in vivo Immunology 66:600-605
2. Beutler, B., and G. E. Grau. 1993 Tumor necrosis factor in the pathogenesis of infectious diseases, Crit. Care Med. 21:5423-5435.
3. Bromberg, J. S., K. D. Chavin, and S. L. Kunkel. 1992 Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J. Immunol. 148:3412-3417.
4. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
5. Clark, I. A., and G. Chaudri. 1988. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis Br. J Haematol 70:99-103.
6. Clark, I. A., K. A. Rockett, and W. B. Cowden. 1992 TNF in malaria. p. 303-328. In B Beutler (ed.), Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, Ltd., New York.
7. de Kossodo, S., and G. E. Grau. 1993. Profiles of cytokine production in relation with susceptibility to cerebral malaria J Immunol. 151:4811-4820
8. Dockrell, H. M., J. B. de Souza, and J. H. L. Playfair. 1980 The role of the liver in immunity to blood-stage murine malaria Immunology 41:421-430.
9. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1220-1212.
10. Harbrecht, B. G., M. Di Silvio, A. J. Demetris, R. L. Simmons, and T. R. Billiar. 1994 Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 20:1055-1060
11. Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli. and J. A. Hamilton. 1989. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor-α, interleukin 1, and prostaglandin E2. Proc. Natl Acad. Sci. USA 86:3803-3807
12. Havell, E. A. 1987. Production of tumor necrosis factor during murine listeriosis. J. Immunol. 139:4225-4231.
13. Hsieh, C., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4+ cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
14. Jacobs, P., D. Radzioch, and M. M. Stevenson. 1995. Nitric oxide in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice J. Immunol. 155:5306-5313.
15. Jacobs, P., D. Radzioch, and M. M. Stevenson. 1996. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not interleukin-4. during blood-stage malaria in mice. Infect. Immun. 64:44-49.
16. Johnson, L. L. 1992. A protective role for endogenous tumor necrosis factor in Toxoplasma gondu infection. Infect. Immun. 60:1979-1983
17. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993 Mice that lack the interferon gamma receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaceharide. J. Exp. Med 178:1435-1440.
18. Karunaweera, N. D., G. E. Grau, P. Gamage, R. Carter, and K. N. Mendis. 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysm in Plasmodium vivax malaria Proc Natl. Acad. Sci. USA 89:3200-3203
19. Kwiatkowski, D., A. V. S. Hill, I. Sambou, P. Twumasi, J. Castracane, K. R. Manogue, A. Cerami, D. R. Brewster, and B. M. Greenwood. 1990 TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204.
20. Kwiatkowski, D., M. E. Molyneax, S. Stephens, N. Curtis, N. Klein, P. Pointaire, M. Smit, R. Allen, D. R. Brewster, G. E. Grau, and B. M. Greenwood. 1993 Anti-TNF therapy inhibits fever in cerebral malaria. O. J. Med. 86:91-98.
21. Langhorne, J. 1989 The role of CD4+ T-cells in the immune response to Plasmodium chabaudi. Parasitol. Today 5:362-364.
22. Mortensen, R. F., F. Gervais, E. Skamene, D. Rae. and M. M. Stevenson. 1985. Acute phase reactants and host resistance: role of mouse serum amyloid P-component, p. 585-594. In E. Skamene (ed.). Progress in leukocyte biology, vol. 3. Genetic control of host resistance to infection and malignancy Alan R. Liss, Inc., New York.
23. Nüssler, A., J. Drapier, L. Rénia, S. Pied, F. Miltgen, M. Gentilini, and D. Mazier. 1991. L-Arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol. 21:227-230.
24. - T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immun. 59:51-58
25. Radzioch, D., M. Clayton, and L. Varesio. 1987. Interferon-α, -β, and -γ augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts J. immunol. 139:805-812.
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989 Molecular cloning: a laboratory manual, 2nd ed., vol. 1, p. 7.36-7.58. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N Y.
27. Schmidt, H. H. H. W., and U. Walter. 1994. NO at work. Cell 78:919-925
28. Sheenan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol. 142:3884-3893.
29. Stevenson, M. M., and E. Ghadirian. 1989. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect. Immun. 57:3936-3939.
30. Stevenson, M. M., D. Y. Huang, J. E. Podoba, and M. E. Nowotarski. 1992. Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice Infect. Immun 60:1193-1201.
31. Stevenson, M. M., and M. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 91:77-83.
32. Stevenson, M. M., M. Tam, and D. Rae. 1990. Dependence on cell-mediated mechanisms for the appearance of crisis forms during Plasmodium chabaudi AS infection in C57BL/6 mice Microb. Pathog. 9:303-314.
33. Stevenson, M. M., M. Tam, S. F. Wolf, and A. Sher. 1995 IL-12 induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via an NO-dependent mechanism. J. Immunol. 155:2545-2556.
34. Taverne, J., D. Rahman, H. M. Dockrell, A. Alavi, C. Leveton, and J. H. L. Playfair. 1987. Activation of liver macrophages in murine malaria is enhanced by vaccination. Clin. Exp Immunol 70:508-514
35. Taverne, J., N. Sheikh, J. B. de Souza, J. H. L. Playfair, L. Probert, and G. Kollias. 1994 Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology 82:397-403.
36. Taverne, J., J. Tavernier, W. Fiers, and J. H. L. playfair. 1987. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro Clin. Exp. Immunol 67:1-4.
37. Urquhart, A. D. 1994. Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria. Clin. Infect. Dis. 19:117-131
38. Waki, S., S. Uehara, K. Kanbe, K. Ono, M. Suzuki, and H. Nariuchi. 1992. The role of T cells in pathogenesis and protective immunity to murine malaria. Immunology 75:646-651.